Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
100mg
|
|||
Strength
150mg
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Zydelig is a prescription medication primarily utilized in the treatment of certain types of blood cancers, particularly chronic lymphocytic leukemia (CLL), B-cell non-Hodgkin lymphoma (HL), and relapsed small lymphocytic lymphoma (SLL).
Zydelig belongs to a class of drugs known as phosphoinositide 3-kinase (PI3K) inhibitors. By targeting specific enzymes involved in the development and survival of cancer cells, Zydelig helps slow down cancer progression and improves patient health outcomes.
Fact Table | |
---|---|
Formula | C22H18FN7O |
License | FDA approved |
Bioavailability | Approximately 57% |
Legal status | Prescription only |
Chemical Name | 5-Fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]quinazolin-4(3H)-one |
Elimination half-life | Approximately 8.2 hours |
Dosage (Strength) | 100 mg, 150 mg tablets |
Pregnancy | Not recommended; consult a healthcare provider |
Brands | Zydelig |
Protein binding | Approximately 93% |
PubChem CID | 11625830 |
MedlinePlus | a614050 |
ChEBI | 85967 |
ATC code | L01XX47 |
DrugBank | DB09054 |
KEGG | D10216 |
Routes of administration | Oral |
The usual starting dose is 150 mg by mouth twice daily.
The active ingredient in Zydelig is idelalisib.
Common drug-drug interactions with Zydelig may include:
Before starting treatment, tell your doctor if you have a history of kidney or liver problems.
Zydelig can cause skin reactions. If you experience a severe skin reaction, stop taking the drug and tell your healthcare provider right away.
Your doctor should monitor the levels of your blood cells during treatment.
Do not take this drug if you are pregnant or planning to become pregnant. Do not take this drug if you are breastfeeding.
Zydelig has many potential drug-drug interactions. Before starting this drug, discuss your entire medication list with your pharmacist and doctor.
The most common adverse reactions may include:
Zydelig [package insert]. Foster City, CA: Gilead; July 2014.